MedTrace Logo

FX Shoulder Prospective Clinical Study

NCT06078865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-02-09

No results posted yet for this study

Summary

Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.

Conditions

  • Osteoarthritis Shoulder
  • Rotator Cuff Syndrome of Shoulder and Allied Disorders
  • Fracture, Shoulder

Interventions

DEVICE

FX Artificial Shoulder Prosthesis

Humelock II Anatomic Shoulder System, Humelock II Reversible Shoulder System, Humelock Reverse Shoulder System, Humeris Shoulder System, Easytech Anatomical Shoulder System, FXV135 Mini Shoulder System, FXV135 Humelock Shoulder System

Sponsors & Collaborators

  • FX Shoulder Solutions

    lead INDUSTRY

Principal Investigators

  • Kathy Trier, PhD · FX Shoulder Solutions

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2031-12-30
Completion
2031-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06078865 on ClinicalTrials.gov